Skip to main content

Alcoholic Hepatitis Syndrome: Prognosis and Course

  • Chapter
Current Perspectives in Hepatology

Abstract

The alcoholic hepatitis syndrome is a disease that is relatively easy to define for groups of patients. It is much more difficult to define for individual patients. This acute disorder of the liver is characterized by a history of excessive alcohol intake, by jaundice and hepatomegaly, and by laboratory abnormalities that include increased serum aminotransferase and alkaline phosphatase activity and leukocytosis composed largely of neutrophils. Prolongation of prothrombin time is common. Fever, ascites, and splenomegaly are often present. Abdnominal pain and anorexia occur frequently.

Long quaffing maketh a short lyfe. John Lyly

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rankin JGD, Orrego-Matte H, Deschenes J, et al: Alcoholic liver disease: The problem of diagnosis. Alcoholism: Clin Exp Res 2:327–328, 1978.

    Article  CAS  Google Scholar 

  2. Kryger S, Schlichting O, Dietrichson O, et al: The accuracy of the clinical diagnosis in acute hepatitis and alcoholic liver disease. Clinical versus morphological diagnosis. Scand J Gastroenterol 18:691–696, 1983.

    Article  PubMed  CAS  Google Scholar 

  3. Poynard T, Degott C, Munoz C, et al: Relationship between degree of portal hypertension and liver histologic lesions in patients with alcoholic cirrhosis. Effect of acute alcoholic hepatitis on portal hypertension. Dig Dis Sci 32:337–343, 1987.

    Article  PubMed  CAS  Google Scholar 

  4. Helman RA, Temko SS, Nye SW, et al: Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy. Ann Intern Med 74:311–321, 1987.

    Google Scholar 

  5. Conn HO, Blei AT, Chojkier M, et al: The naked physician: The blind interpretation of liver function tests in the differential diagnosis of jaundice, in Preisig R, Bircher J (eds): The Liver: Quantitative Aspects of Structure and Function. Third International Gstaad Symposium, Gstaad, 1978, pp. 386–394.

    Google Scholar 

  6. Morris JS, Gallo GA, Scheuer PJ, et al: Percutaneous liver biopsy in patients with large bile duct obstruction. Gastroenterology 68:750–754, 1975.

    PubMed  CAS  Google Scholar 

  7. Morgan MY, Sherlock S: Sex-related differences among 100 patients with alcoholic liver disease. Br Med J 1:939–941, 1977.

    Article  PubMed  CAS  Google Scholar 

  8. Orrego H, Blendis LM, Crossley IR, et al: Correlation of intrahepatic pressure with collagen in the Disse space and hepatomegaly in humans and in the rat. Gastroenterology 80:546–556, 1981.

    PubMed  CAS  Google Scholar 

  9. Skrainka B, Stahlhut J, Fulbeck CL, et al: Measuring liver span. Bedside examination versus ultrasound and scintiscan. J Clin Gastroenterol 8:267–270, 1986.

    Article  PubMed  CAS  Google Scholar 

  10. Espinoza P, Ducot B, Pelletier G, et al: Interobserver agreement in the physical diagnosis of alcoholic liver disease. Dig Dis Sci 32:244–247, 1987.

    Article  PubMed  CAS  Google Scholar 

  11. Rasmussen SN: Liver volume by ultrasonic scanning. Br J Radiol 45:579, 1972.

    Article  PubMed  CAS  Google Scholar 

  12. Weiss JS, Gautam A, Lauff JJ, et al: The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia. S Engl J Med 309:147–150, 1983.

    Article  CAS  Google Scholar 

  13. Sanchez-Tapias JM, Fiol B, Rodes J: (+)-Cyanidanol-3 in mild alcoholic hepatitis, in Conn HO (ed): International Workshop on (+)-Cyanidanol-3 in Diseases of the Liver. Royal Society of Medicine, Academic Press, London and Grune and Stratton, New York, 1981, pp. 173–175.

    Google Scholar 

  14. Palmas S: Treatment of alcoholic cirrhosis with (+)-Cyanidanol-3, in Conn HO (ed): International Workshop on (+)-Cyanidanol-3 in Diseases of the Liver. Royal Society of Medicine, Academic Press, London and Grune and Stratton, New York, 1981, pp. 167–171.

    Google Scholar 

  15. Zimmerman HJ, Seeff LB: Enzymes in hepatic disease, in Coodley EL (ed): Diagnostic Enzymology. Philadelphia, Lea & Febiger, 1970, pp. 1–38.

    Google Scholar 

  16. Cohen JA, Kaplan MM: The SGOT/SGPT Ratio—An indicator of alcoholic liver disease. Dig Dis Sci 24:835–838, 1979.

    Article  PubMed  CAS  Google Scholar 

  17. Nalpas B, Vassault A, Charpin S, et al: Serum mitochondrial asparate aminotransferase as a marker of chronic alcoholism: Diagnostic value and interpretation in a liver unit. Hepatology 6:608–614, 1986.

    Article  PubMed  CAS  Google Scholar 

  18. Orrego H, Kalant H, Israel Y, et al: Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease. Gastroenterology 76:105–115, 1979.

    PubMed  CAS  Google Scholar 

  19. Maddrey WC, Boitnott JK, Bedine MS, et al: Adrenocosteroid therapy of alcoholic hepatitis. Gastroenterology 75:193–199, 1978.

    PubMed  CAS  Google Scholar 

  20. Maddrey WC, Carithers JR RL, Herlong HF, et al: Prednisolone therapy in patients with severe alcoholic hepatitis. Results of a multicenter trial. Hepatology 6:1202, 1986 (abst).

    Google Scholar 

  21. Conn HO: The management of alcoholic hepatitis, in Conn HO (ed): International Workshop on (+)-Cyanidanol-3 in Diseases of the Liver. Royal Society of Medicine, Academic Press, London and Grune and Stratton, New York, 1981, pp. 147–156.

    Google Scholar 

  22. Hallak A, Conn HO: Prognostic value of blood tests in alcoholic hepatitis (AH). Analysis of the randomized clinical trials (RCT). (in preparation)

    Google Scholar 

  23. Porter HP, Simon FR, Pope CE, et al: Corticosteroid therapy in severe alcoholic hepatitis: A double-blind drug trial. S Engl J Med 284:1350–1355, 1971.

    Article  CAS  Google Scholar 

  24. Campra JL, Hamlin EM, Kirshbaum RJ, et al: Prednisone therapy of acute alcoholic hepatitis: Report of a controlled trial. Ann Intern Med 79:625–631, 1973.

    PubMed  CAS  Google Scholar 

  25. Blitzer BL, Mutchnick MG, Joshi PH, et al: Adrenocorticosteroid therapy in alcoholic hepatitis: A prospective, double-blind randomized study. Am J Dig Dis 22:477–484, 1977.

    Article  PubMed  CAS  Google Scholar 

  26. Lesesne HR, Bozymski EM, Fallon HJ: Treatment of alcoholic hepatitis with encephalopathy: Comparison of prednisolone with caloric supplements. Gastroenterology 74:169–173, 1978.

    PubMed  CAS  Google Scholar 

  27. Shumaker JB, Resnick RH, Galambos JT, et al: A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. Am J Gastroenterol 69:443–449, 1978.

    PubMed  CAS  Google Scholar 

  28. Depew W, Boyer T, Omata M, et al: Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy. Gastroenterology 78:524–529, 1980.

    PubMed  CAS  Google Scholar 

  29. Mendenhall CL, Anderson S, Garcia-Pont P, et al: Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. S Engl J Med 23:1464–1470, 1984.

    Article  Google Scholar 

  30. The Copenhagen Study Group for Liver Diseases: Testosterone treatment of men with alcoholic cirrhosis. A double-blind study. Hepatology 6:807–813, 1986.

    Article  Google Scholar 

  31. Nasrallah SM, Galambos JT: Aminoacid therapy of alcoholic hepatitis. Lancet 2:1276–1277, 1980.

    Article  PubMed  CAS  Google Scholar 

  32. Diehl AM, Boitnott JK, Herlong F, et al: Effect of parenteral amino acid supplementation in alcoholic hepatitis. Hepatology 5:57–63, 1985.

    Article  PubMed  CAS  Google Scholar 

  33. Baker AL, Jaspan JB, Haines NW, et al: A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: Progress report in 50 patients. Gastroenterology 80:1410–1414, 1981.

    PubMed  CAS  Google Scholar 

  34. Halle P, Pare P, Kaptein E, et al: Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis. Gastroenterology 82:925–931, 1982.

    PubMed  CAS  Google Scholar 

  35. Resnick RH, Boitnott J, Iber FL, et al: Preliminary observations of d-penicillamine therapy in acute alcoholic liver disease. Digestion 11:257–265, 1974.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Plenum Publishing Corporation

About this chapter

Cite this chapter

Conn, H.O., Hallak, R. (1989). Alcoholic Hepatitis Syndrome: Prognosis and Course. In: Seeff, L.B., Lewis, J.H. (eds) Current Perspectives in Hepatology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7041-3_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-7041-3_18

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-7043-7

  • Online ISBN: 978-1-4684-7041-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics